(Post-pandemic Era)-Global Drug-Eluting Bioabsorbable Stents Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Report Code : XYZ2157158
- Published On: Dec, 2020
- Category : Medical Devices
- Pages : 114
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Drug-Eluting Bioabsorbable Stents market in this environment.
In terms of revenue, this research report indicated that the global Drug-Eluting Bioabsorbable Stents market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Drug-Eluting Bioabsorbable Stents industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Medtronic aims at producing XX Drug-Eluting Bioabsorbable Stents in 2020, with XX % production to take place in global market, B.Braun Melsungen accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Drug-Eluting Bioabsorbable Stents Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Drug-Eluting Bioabsorbable Stents Market
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Major Type of Drug-Eluting Bioabsorbable Stents Covered in Research report:
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Application Segments Covered in Research report:
Coronary Artery Diseases
Peripheral Artery Diseases
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Drug-Eluting Bioabsorbable Stents Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Serolimus and Paclitaxel Drug-Eluting Stents -Product Introduction and Major Manufacturers
1.1.2 Sirolimus Drug Eluting Stents -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Drug-Eluting Bioabsorbable Stents Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis3.1 China Drug-Eluting Bioabsorbable Stents Market
3.1.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)3.2 EU Drug-Eluting Bioabsorbable Stents Market
3.2.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)3.3 USA Drug-Eluting Bioabsorbable Stents Market
3.3.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)3.4 Japan Drug-Eluting Bioabsorbable Stents Market
3.4.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)3.5 India Drug-Eluting Bioabsorbable Stents Market
3.5.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)3.6 Southeast Asia Drug-Eluting Bioabsorbable Stents Market
3.6.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Drug-Eluting Bioabsorbable Stents Market
3.7.1 Top Companies leading Drug-Eluting Bioabsorbable Stents Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Drug-Eluting Bioabsorbable Stents Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)4.1 Drug-Eluting Bioabsorbable Stents Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Drug-Eluting Bioabsorbable Stents Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)5.1 Global Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2021-2026)
5.2 Global Drug-Eluting Bioabsorbable Stents Sales Value and Growth Rate (2021-2026)
6 Drug-Eluting Bioabsorbable Stents Competitive Analysis6.1 Medtronic
6.1.1 Medtronic Company Profiles
6.1.2 Medtronic Product Introduction
6.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.1.4 SWOT Analysis6.2 B.Braun Melsungen
6.2.1 B.Braun Melsungen Company Profiles
6.2.2 B.Braun Melsungen Product Introduction
6.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.2.4 SWOT Analysis6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Profiles
6.3.2 Abbott Laboratories Product Introduction
6.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.3.4 SWOT Analysis6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Company Profiles
6.4.2 Boston Scientific Corporation Product Introduction
6.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.4.4 SWOT Analysis6.5 Biosensors International
6.5.1 Biosensors International Company Profiles
6.5.2 Biosensors International Product Introduction
6.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.5.4 SWOT Analysis6.6 Terumo Corporation.
6.6.1 Terumo Corporation. Company Profiles
6.6.2 Terumo Corporation. Product Introduction
6.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 MicroPort Scientific Corporation
6.7.1 MicroPort Scientific Corporation Company Profiles
6.7.2 MicroPort Scientific Corporation Product Introduction
6.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Alvimedica
6.8.1 Alvimedica Company Profiles
6.8.2 Alvimedica Product Introduction
6.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Biotronik
6.9.1 Biotronik Company Profiles
6.9.2 Biotronik Product Introduction
6.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.9.4 SWOT Analysis6.10 Elixir Medical Corporation
6.10.1 Elixir Medical Corporation Company Profiles
6.10.2 Elixir Medical Corporation Product Introduction
6.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Innovative Health Technologies
7 Conclusion
-
The (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
(Post pandemic Era) Global Drug Eluting Bioabsorbable Stents has a wide range of applications, including
In recent years, the (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
According to the (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
During the forecast years, the (Post pandemic Era) Global Drug Eluting Bioabsorbable Stents Market can thrive with a robust CAGR.
